tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HOTH Stock Latest News

Hoth Therapeutics Faces Digital Asset Industry Challenges
Company AnnouncementsHoth Therapeutics Faces Digital Asset Industry Challenges
7d ago
8K
HOTH
Hoth Therapeutics submits CTA to EMA to expand Phase II trial of HT-001
PremiumThe Fly
Hoth Therapeutics submits CTA to EMA to expand Phase II trial of HT-001
9d ago
HOTH
Hoth Therapeutics’ cancer therapeutic HT-KIT shows efficacy, safety
PremiumThe Fly
Hoth Therapeutics’ cancer therapeutic HT-KIT shows efficacy, safety
17d ago
HOTH
Hoth Therapeutics Renews CEO Contract Amidst Patent Filing
PremiumCompany Announcements
Hoth Therapeutics Renews CEO Contract Amidst Patent Filing
28d ago
8K
HOTH
Hoth Therapeutics Holds Annual Shareholder Meeting
PremiumCompany Announcements
Hoth Therapeutics Holds Annual Shareholder Meeting
1M ago
8K
HOTH
Hoth Therapeutics extending Phase II trial of HT-001 in cancer patients to EU
PremiumThe FlyHoth Therapeutics extending Phase II trial of HT-001 in cancer patients to EU
2M ago
HOTH
Hoth Therapeutics signs VA research deal to advance GDNF in obesity, fatty liver
Premium
The Fly
Hoth Therapeutics signs VA research deal to advance GDNF in obesity, fatty liver
2M ago
HOTH
Psychedelic: Compass Pathways achieves primary endpoint in COMP360 trial
Premium
The Fly
Psychedelic: Compass Pathways achieves primary endpoint in COMP360 trial
3M ago
CMND
CMPS
Silo Pharma enters into letter of intent to form 50:50 joint venture with Hoth
PremiumThe Fly
Silo Pharma enters into letter of intent to form 50:50 joint venture with Hoth
3M ago
HOTH
SILO
Hoth and Silo form strategic joint venture to develop obesity treatment
PremiumThe Fly
Hoth and Silo form strategic joint venture to develop obesity treatment
3M ago
HOTH
SILO
Hoth Therapeutics Advances HT-001 for Cancer Treatment
PremiumCompany Announcements
Hoth Therapeutics Advances HT-001 for Cancer Treatment
3M ago
8K
HOTH
Hoth Therapeutics says HT-001 met primary endpoint in CLEER-001 study
PremiumThe Fly
Hoth Therapeutics says HT-001 met primary endpoint in CLEER-001 study
3M ago
HOTH
Hoth Therapeutics Regains Nasdaq Compliance on June 18
PremiumCompany AnnouncementsHoth Therapeutics Regains Nasdaq Compliance on June 18
3M ago
8K
HOTH
Hoth Therapeutics reports results from multi-dose study of HT-KIT
Premium
The Fly
Hoth Therapeutics reports results from multi-dose study of HT-KIT
3M ago
HOTH
Hoth Therapeutics granted Japanese patent for HT-KIT platform
Premium
The Fly
Hoth Therapeutics granted Japanese patent for HT-KIT platform
3M ago
HOTH
Hoth Therapeutics announces Expanded Access Program aplication for HT-001
PremiumThe Fly
Hoth Therapeutics announces Expanded Access Program aplication for HT-001
3M ago
HOTH
Hoth Therapeutics Prepares Presentation on Clinical Programs
PremiumCompany Announcements
Hoth Therapeutics Prepares Presentation on Clinical Programs
3M ago
8K
HOTH
Hoth Therapeutics Faces Nasdaq Compliance Challenge
PremiumCompany Announcements
Hoth Therapeutics Faces Nasdaq Compliance Challenge
4M ago
8K
HOTH
Hoth Therapeutics reports preclinical data for HT-KIT
PremiumThe Fly
Hoth Therapeutics reports preclinical data for HT-KIT
4M ago
HOTH
Hoth Therapeutics granted Japanese patent for novel RNA-based cancer therapy
PremiumThe FlyHoth Therapeutics granted Japanese patent for novel RNA-based cancer therapy
5M ago
HOTH
Hoth Therapeutics Reports Positive Phase 2a Trial Results
Premium
Company Announcements
Hoth Therapeutics Reports Positive Phase 2a Trial Results
5M ago
8K
HOTH
Hoth Therapeutics’ HT-001 shows efficacy in Phase 2a pruritus trial
Premium
The Fly
Hoth Therapeutics’ HT-001 shows efficacy in Phase 2a pruritus trial
5M ago
HOTH

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >